| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Phenolphthalein (a triphenylmethane derivative) has been commonly used as a laxative for most of the twentieth century, but little is known about its long-term carcinogenic potential in experimental studies. In our studies, phenolphthalein administered continuously in the feed for 2 years to F344 rats at doses of 0, 12,500, 25,000, and 50,000 ppm and to C57BL/6 x CH3 F1 (hereafter called B6C3F1) mice at doses of 0, 3,000, 6,000, and 12,000 ppm caused multiple carcinogenic effects. Treatment-related neoplasms occurred in the kidney and adrenal medulla in male rats, adrenal medulla in female rats, hematopoietic system in male and female mice (histiocytic sarcomas and malignant lymphomas), and ovary of female mice. Phenolphthalein has been shown to have estrogenic and clastogenic properties. Previous studies of other estrogenic chemicals (e.g., zearalenone) in the F344 rat and B6C3F1 mouse have not shown the same spectrum of carcinogenic activity as that found with phenolphthalein, suggesting that phenolphthalein estrogenic activity alone is not responsible for the spectrum of tumors observed. It is more likely that the multiple biological properties of phenolphthalein, including its ability to form free radicals, its clastogenic activity, and its estrogenic activity, contributed to the carcinogenic effects observed. These studies show that phenolphthalein is a multisite/multispecies carcinogen. One of the sites for neoplasm that is of particular concern is the ovary, and epidemiology studies are under way to identify any potential effects of phenolphthalein exposure at this site in humans.
1 To whom requests for reprints should be addressed, at National Institute of Environmental Health Science, P. O. Box 12233, Research Triangle Park, NC 27709.
Received 6/14/96. Accepted 8/30/96.
This article has been cited by other articles:
|
|
 |
|
  R. E. Stoll, K. T. Blanchard, J. H. Stoltz, J. B. Majeska, S. Furst, P. D. Lilly, and J. H. Mennear Phenolphthalein and Bisacodyl: Assessment of Genotoxic and Carcinogenic Responses in Heterozygous p53 (+/-) Mice and Syrian Hamster Embryo (SHE) Assay Toxicol. Sci., April 1, 2006; 90(2): 440 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Morton, R. S. Sellers, S. M. Furst, K. D. Hawley, and J. R. May Effect of Oral Gavage Dosing Regimens in Female Tg rasH2 Transgenic Mice Toxicol Pathol, June 1, 2004; 32(4): 413 - 417. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Karlsson, P. Soderkvist, and S.-M. Zhuang Point Mutations and Deletions in the Znfn1a1/Ikaros Gene in Chemically Induced Murine Lymphomas Cancer Res., May 1, 2002; 62(9): 2650 - 2653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Hulla, J. E. French, and J. K. Dunnick Chromosome 11 Loss from Thymic Lymphomas Induced in Heterozygous Trp53 Mice by Phenolphthalein Toxicol. Sci., April 1, 2001; 60(2): 264 - 270. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Hulla, J. E. French, and J. K. Dunnick Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice Carcinogenesis, January 1, 2001; 22(1): 89 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. F. Coogan, L. Rosenberg, J. R. Palmer, B. L. Strom, A. G. Zauber, P. D. Stolley, and S. Shapiro Phenolphthalein Laxatives and Risk of Cancer J Natl Cancer Inst, December 6, 2000; 92(23): 1943 - 1944. [Full Text] [PDF]
|
|
|
|
|
|
B. J. Collins, T. B. Grizzle, and J. K. Dunnick Toxicokinetics of Phenolphthalein in Male and Female Rats and Mice Toxicol. Sci., August 1, 2000; 56(2): 271 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Pommer, E. Bronder, A. Klimpel, U. Helmert, E. Greiser, and M. Molzahn Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study Nephrol. Dial. Transplant., December 1, 1999; 14(12): 2892 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Dunnick, J. F. Hardisty, R. A. Herbert, J. C. Seely, E. M. Furedi-Machacek, J. F. Foley, G. D. Lacks, S. Stasiewicz, and J. E. French Phenolphthalein Induces Thymic Lymphomas Accompanied by Loss of the p53 Wild Type Allele in Heterozygous p53-Deficient ({+/-}) Mice Toxicol Pathol, November 1, 1997; 25(6): 533 - 540. [Abstract] [PDF]
|
|
|
|
 |
|
 H. J. Sipe Jr., J. T. Corbett, and R. P. Mason In vitro free radical metabolism of phenolphthalein by peroxidases Drug Metab. Dispos., April 1, 1997; 25(4): 468 - 480. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
